Research on a revolutionary injection to treat genetic heart diseases begins
LONDON: An international team of scientists and cardiologists has been awarded £30 million to research a revolutionary injection to treat genetic heart disease.
In fact, this is a huge non-profit grant that will make it possible to save the lives of thousands of people who suffer from ‘hitherto’ incurable heart disease due to a specific genetic defect.
The money has been awarded to a small research group, CureHeart, which aims to develop the most accurate gene therapy to find a solution to hereditary heart disease. Surprisingly, this therapy will be in the form of a vaccine.
Scientists from the United Kingdom, the United States and Singapore are also included in this panel, in which the medical and scientific advisors of the British government are also present. In this genetic condition, the heart stops suddenly and the patient dies or progresses rapidly to heart failure.
This is called genetic cardiomyopathies in medical language. Half of their patients require a heart donation because the disease is incurable and donations are limited. It is estimated that one in 250 people around the world may suffer from this condition and in the UK alone it has more than 250,000 patients.
The vaccine will use a technology called CRI-SPR, thanks to which the patients’ DNA will be rewritten or the faulty gene corrected, but experts have thought about improving this technique. Is.